Role of Craving in the Transition Across Level of Addiction Severity: A Longitudinal Study.

ConditionAddiction
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Bordeaux

About this trial

Substance/Alcohol Use disorders are defined as a loss of control over the use despite harmul consequences, as well as an intense and persistent urge to use, also called craving. Previous research has shown that craving is central among the diagnostic criteria for addiction, suggesting that it may be important in the onset and persistence of addiction.

Addiction develops progressively, and it appears crucial to identify predictive markers of the transition from one level of severity to another over time. One hypothesis is that more closely linked symptoms (meaning symptoms that influence each other more) could be associated with greater severity and/or with the evolution of addiction severity over time.

The aim of this project is to explore how the characteristics of the association between addiction symptoms (diagnostic criteria and symptoms as they occur in daily life), and the importance of craving relative to other symptoms, could serve as markers of different addiction severities and of the transition across these levels of severity.

Eligibility criteria

Qualifiers

Be over 18 years of age

Identify a primary substance as a main problematic substance use.

Be a regular user (at least twice a week in the last 30 days) of a primary substance (defined as their main problematic substance use).

Present a current diagnosis of SUD for this primary substance according to DSM-5 criteria.

Disqualifiers

Medical, psychiatric or addiction condition that warrants immediate inpatient treatment intervention.

Somatic, cognitive or other disorders preventing the use of the smartphone device (deafness, impaired vision, illiteracy….).

Not being familiar with the use of smartphone

Having a smartphone not compatible with the application and being unable to visit the laboratory to receive a loaner phone for the study.

Trial design

Treatments tested in this trial

  • Observational assessments (EMA and annual DSM-5 evaluations)

Treatment groups

700 Participants
are divided into 5 treatment groups

Sponsors and collaborators

University of Bordeaux

Lead sponsor

Hospices Civils de Lyon

Collaborator